Values First Advisors’s ESSA Pharma EPIX Stock Holding History

Values First Advisors’s Portfolio EPIX Stock Details EPIX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-14,605	Closed	-$46K	–	157
2022 Q2	$46K	Buy	14,605 +2,521	+21%	+$14.1K	0.03%	151
2022 Q1	$75K	Sell	12,084 -1,584	-12%	-$13.9K	0.05%	155
2021 Q4	$194K	Buy	13,668 +2,892	+27%	+$32.2K	0.11%	160
2021 Q3	$86K	Buy	+10,776	New	+$171K	0.06%	139

Other funds holding EPIX

BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

APM

Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

RPAM

Rhenman & Partners Asset Management Stockholm, Sweden $1.06B AUM 52.03% 1-Year Est. Return

Values First Advisors's EPIX Position: Q3 2022 in Review

Values First Advisors sold out of ESSA Pharma (EPIX) in Q3 2022, closing a stake of 14,605 shares — an estimated $46K sold.

Values First Advisors first reported a position in EPIX in Q3 2021 and held it in 4 quarters. The position peaked at $194K in Q4 2021. 54 funds tracked by Wall St. Rank hold EPIX as of Q3 2022.

Values First Advisors reported no remaining ESSA Pharma position as of Q3 2022 after selling out during the quarter.
Values First Advisors sold 14,605 ESSA Pharma shares in Q3 2022, an estimated $46K.
Values First Advisors first reported a position in ESSA Pharma in Q3 2021 and held it in 4 quarters.
Values First Advisors's ESSA Pharma position peaked at $194K in Q4 2021.
54 funds tracked by Wall St. Rank held ESSA Pharma as of Q3 2022.

Based on Values First Advisors's 13F filing for Q3 2022, filed 2 Dec 2022.